New pill aims to keep leukemia in check for chinese patients
NCT ID NCT07458542
First seen Mar 10, 2026 · Last updated May 11, 2026 · Updated 6 times
Summary
This study looks at how well and how safely the oral drug ONUREG works in Chinese adults with acute myeloid leukemia (AML) who have already achieved remission after chemotherapy. The goal is to see if taking this pill can help keep the cancer from coming back. The study involves 44 participants in Hong Kong who cannot or choose not to have a stem cell transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong
Hong Kong, China
Conditions
Explore the condition pages connected to this study.